Literature DB >> 24035147

Midlife risk score for the prediction of dementia four decades later.

Lieza G Exalto1, Charles P Quesenberry2, Deborah Barnes3, Miia Kivipelto4, Geert Jan Biessels2, Rachel A Whitmer5.   

Abstract

OBJECTIVE: The objective of this study was to obtain external validation of the only available midlife dementia risk score cardiovascular risk factors , aging and dementia study (CAIDE) constituting age, education, hypertension, obesity, and hyperlipidemia in a larger, more diverse population. Our second aim was to improve the CAIDE risk score by additional midlife risk factors.
METHODS: This retrospective cohort study was conducted in an integrated health care delivery system. A total of 9480 Kaiser Permanente members who participated in a health survey study (age range, 40-55 years) from 1964 to 1973 were included in this study. Dementia diagnoses from primary care and medical specialist visits were collected from January 1, 1994 to January 16, 2006, using International Classification of Diseases 9 codes 290.0, 290.1 for "possible dementia," and 331.0 and 290.4 for "specialist confirmed dementia." Risk model prediction and validation were examined with the C statistic, net reclassification improvement, and integrated discrimination improvement. Dementia risk per sum score was calculated with Kaplan-Meier estimates.
RESULTS: A total of 2767 participants (25%) were diagnosed with any type of dementia, of which 1011 diagnoses (10.7%) were specialist-confirmed diagnoses. Average time between midlife examination and end of follow-up was 36.1 years. The CAIDE risk score replicated well with a C statistic of 0.75, quite similar to the original CAIDE C statistic of 0.78. The CAIDE score also predicted well within different race strata. Other midlife risk factors (central obesity, depressed mood, diabetes mellitus, head trauma, lung function, and smoking) did not improve predictability. The risk score allowed stratification of participants into those with 40-year low (9%) and high (29%) dementia risk.
CONCLUSIONS: A combination of modifiable vascular risk factors in midlife is highly predictive of the likelihood of dementia decades later. Possible dementia prevention strategies should point to a life course perspective on maintaining vascular health.
Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Age; Alzheimer's disease; CAIDE; Dementia; Depressed mood; Diabetes mellitus; Education; Head trauma; Hyperlipidemia; Hypertension; Lung function; Obesity; Prevention; Risk score; Smoking; Validation; Vascular dementia

Mesh:

Year:  2013        PMID: 24035147     DOI: 10.1016/j.jalz.2013.05.1772

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  71 in total

Review 1.  A major role for cardiovascular burden in age-related cognitive decline.

Authors:  Chengxuan Qiu; Laura Fratiglioni
Journal:  Nat Rev Cardiol       Date:  2015-01-13       Impact factor: 32.419

2.  Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.

Authors:  Teresa Jenica Filshtein; Brittany N Dugger; Lee-Way Jin; John M Olichney; Sarah T Farias; Luis Carvajal-Carmona; Paul Lott; Dan Mungas; Bruce Reed; Laurel A Beckett; Charles DeCarli
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

3.  Traumatic brain injury history and progression from mild cognitive impairment to Alzheimer disease.

Authors:  Christian LoBue; Fu L Woon; Heidi C Rossetti; Linda S Hynan; John Hart; C Munro Cullum
Journal:  Neuropsychology       Date:  2018-05       Impact factor: 3.295

4.  APOEε4 Genotype and Hypertension Modify 8-year Cortical Thinning: Five Occasion Evidence from the Seattle Longitudinal Study.

Authors:  Philippe Rast; Kristen M Kennedy; Karen M Rodrigue; Paul R A W Robinson; Alden L Gross; Donald G McLaren; Tom Grabowski; K Warner Schaie; Sherry L Willis
Journal:  Cereb Cortex       Date:  2018-06-01       Impact factor: 5.357

5.  Relationship between metabolic and vascular conditions and cognitive decline among older Mexican Americans.

Authors:  Brian Downer; Mukaila A Raji; Kyriakos S Markides
Journal:  Int J Geriatr Psychiatry       Date:  2015-05-29       Impact factor: 3.485

6.  Application of Concordance Probability Estimate to Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease.

Authors:  Xiaoxia Han; Yilong Zhang; Yongzhao Shao
Journal:  Biostat Epidemiol       Date:  2017-07-31

7.  Individualized clinical management of patients at risk for Alzheimer's dementia.

Authors:  Richard S Isaacson; Hollie Hristov; Nabeel Saif; Katherine Hackett; Suzanne Hendrix; Juan Melendez; Joseph Safdieh; Matthew Fink; Madhav Thambisetty; George Sadek; Sonia Bellara; Paige Lee; Cara Berkowitz; Aneela Rahman; Josefina Meléndez-Cabrero; Emily Caesar; Randy Cohen; Pei-Lin Lu; Samuel P Dickson; Mu Ji Hwang; Olivia Scheyer; Monica Mureb; Matthew W Schelke; Kellyann Niotis; Christine E Greer; Peter Attia; Lisa Mosconi; Robert Krikorian
Journal:  Alzheimers Dement       Date:  2019-10-31       Impact factor: 21.566

8.  Early Midlife Pulmonary Function and Dementia Risk.

Authors:  Paola Gilsanz; Elizabeth Rose Mayeda; Jason Flatt; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimer Dis Assoc Disord       Date:  2018 Oct-Dec       Impact factor: 2.703

9.  A Late Life Risk Index for Severe Cognitive Impairment in Mexico.

Authors:  Brian Downer; Sreenivas P Veeranki; Rebeca Wong
Journal:  J Alzheimers Dis       Date:  2016-03-08       Impact factor: 4.472

10.  Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.

Authors:  Jesus D Melgarejo; Daniel C Aguirre-Acevedo; Ciro Gaona; Carlos A Chavez; Gustavo E Calmón; Eglé R Silva; Gabriel A de Erausquin; Mario Gil; Luis J Mena; Joseph D Terwilliger; Humberto Arboleda; Nikolaos Scarmeas; Joseph H Lee; Gladys E Maestre
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.